MoneyWorks4Me

The revenue for the September 2024 quarter is pegged at Rs. 15803.50 millions, about 6.86% up against Rs. 14788.40 millions recorded during the year-ago period.Net profit stood at Rs. 1657.80  millions  compared to Rs. 1338.40 millions in the corresponding previous quarter,high by 23.86%.Operating profit for the quarter ended September 2024 rose to 2755.50 millions as compared to 2164.10 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 15803.50 14788.40 6.86 30559.10 28111.10 8.71 58740.60 51490.00 14.08
Other Income 160.60 89.50 79.44 192.00 208.00 -7.69 313.20 35.40 784.75
PBIDT 2755.50 2164.10 27.33 5701.20 3939.80 44.71 10298.40 6678.80 54.20
Interest 182.80 153.90 18.78 309.70 296.80 4.35 544.70 490.00 11.16
PBDT 2701.40 2010.20 34.38 5520.20 3643.00 51.53 9753.70 6188.80 57.60
Depreciation 701.20 671.80 4.38 1388.00 1329.30 4.42 2711.40 2729.50 -0.66
PBT 2000.20 1338.40 49.45 4132.20 2313.70 78.60 7042.30 3459.30 103.58
TAX 342.40 0.00 0.00 712.50 0.00 0.00 377.50 -8.00 -4818.75
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1657.80 1338.40 23.86 3419.70 2313.70 47.80 6664.80 3467.30 92.22
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 17.44 14.63 19.15 18.66 14.02 33.12 17.53 12.97 35.16
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..